Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is MetaboShield's primary product?
- MetaboShield's primary product is an insertable gastric sleeve, an intestinal sleeve designed to be lodged permanently in the small intestine via the throat in an anesthesia-free procedure.
- What medical conditions is MetaboShield's product intended to address?
- MetaboShield's intestinal sleeve is intended to help people with unwanted weight and potentially assist in reversing Type 2 diabetes.
- When was MetaboShield founded?
- MetaboShield was founded in January 2013.
- What is the current operational status of MetaboShield?
- MetaboShield is currently inactive as of June 2015.
- Where is MetaboShield headquartered?
- MetaboShield is headquartered in Jerusalem, Israel, specifically at Hadassah.
- How many employees does MetaboShield have?
- MetaboShield has 6 employees.
- What is MetaboShield's current funding stage?
- MetaboShield is in the Pre-Funding stage.
- Which organizations were involved in the development of MetaboShield?
- MetaboShield was developed by students at the Hebrew University of Jerusalem's Biodesign program along with team members at the Hadassah Medical Center in Israel.
- What is the primary sector of MetaboShield?
- MetaboShield's primary sector is Health Tech & Life Sciences.